Get started
Author

Vinita Verma

ORCID: 0000-0002-8121-0522
Observed ORCID: 0000-0002-8121-0522
OpenAlex ID: A5102994679
ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer – an interim analysis
2023 · Ronald Tutrone, Ben Lowentritt, et al. · Prostate Cancer and Prostatic Diseases · 63
PDF
Mp19-10 Evaluating Exodx Prostate Test in Men With Low-grade Prostate Cancer on Active Surveillance–a Multi-center Prospective Trial
2025 · Judd Moul, Sanoj Punnen, et al. · The Journal of Urology · 1
PDF
Correction to: ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer – an interim analysis
2023 · Ronald Tutrone, Ben Lowentritt, et al. · Prostate Cancer and Prostatic Diseases · 1
PDF
Evaluating Exodx Prostate Test in Men With Low-grade Prostate Cancer on Active Surveillance - a Multi-center Prospective Trial
2025 · Sonia Kumar, Vinita Verma, et al. · Urologic Oncology Seminars and Original Investigations
PD42-12 CLINICAL IMPACT OF AN INTEGRATED ExoDx PROSTATE BIOMARKER AND mpMRI FOR HGPCA RISK ASSESSMENT: PRACTICE PATTERNS, AND PERFORMANCE IN THE CLINIC
2024 · Sonia Kumar, Christian Ray, et al. · The Journal of Urology
PDF
Mp41-04 Exosome Biomarker Clinical Impact on Timing and Decision to Have a Prostate Biopsy
2024 · Ronald F. Tutrone, Sonia Kumar, et al. · The Journal of Urology
PDF
MP41-07 UTILIZATION OF ExoDx PROSTATE TEST FOR PROSTATE CANCER RISK STRATIFICATION IN THE AFRICAN AMERICAN POPULATION
2024 · Ronald F. Tutrone, Sonia Kumar, et al. · The Journal of Urology
PDF
BPI24-025: Prostate Biopsies Against Medical Advice: Unveiling New Biomarker Insights for Men
2024 · Jason Alter, Sonia Kumar, et al. · Journal of the National Comprehensive Cancer Network
BPI24-026: Utilization of ExoDx Prostate Test for Prostate Cancer Risk Stratification in the African American Population
2024 · Jason Alter, Ronald Tutrone, et al. · Journal of the National Comprehensive Cancer Network
Works count: 9
Citation count: 65
H-index: 1
I10-index: 1
Year
Topic
Type